Facebook Linkedin Tumblr Twitter
Sign in
  • My Account
  • orders
Sign in
Welcome!Log into your account
Forgot your password?
Password recovery
Recover your password
Search
  • Sign in / Join
Facebook Linkedin Tumblr Twitter
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
Market Exclusive #1 Financial News & Analysis Market Exclusive
Market Exclusive #1 Financial News & Analysis
  • My Account
  • orders
Home Biotech Stocks Page 119

Biotech Stocks

Latest
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random

Insys Therapeutics Presents Study Results Showing Rapid Absorption Of Epinephrine

ME Staff - February 26, 2019

Veritas Pharma Doses First Subject In Clinical Study Of CTL-X

OWC Pharmaceutical Cannabis Ointment Set To Proceed To PII After Positive PI Data

Reliq Health Technologies Expands Leadership Team As Investigations Continue

Zynerba Gives Clinical Update, Lifelong Impact Of ZYN002

aaap

Weekly Biotech Report Covering Advanced Accelerator Application SA (ADR) (NASDAQ:AAAP)

David Rich - May 31, 2016 0

Weekly Biotech Report Covering Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) FDA approval of...

David Rich - May 31, 2016 0

Weekly Biotech Report covering AstraZeneca PLC (NSYE:AZN) FDA rejection of ZS-9...

David Rich - May 31, 2016 1
sarepta srpt

Weekly Biotech Report on Sarepta Therapeutics (NASDAQ:SRPT) Battle with FDA on...

David Rich - May 31, 2016 0

Market Exclusive Weekly Biotech Report Covering Sanofi SA (NYSE:SNY) FDA approval...

David Rich - May 31, 2016 0
novo nordisk nvo

Weekly Biotech Report Covering Novo Nordisk A/S (NYSE:NVO)

David Rich - May 31, 2016 0
Minerva

Did Minerva Neurosciences Inc (NASDAQ:NERV) Deserve its End of Week Gains?

- May 30, 2016 1
Flex

Neuroderm Ltd (NASDAQ:NDRM) Could Be About To Enter The Multi-Billion Dollar...

Jennifer Aldershot - May 27, 2016 0

Pfizer Inc. (NYSE:PFE)’s Syphilis Drug Shortage Threatens Affected Individuals

- May 27, 2016 0

NICE Recommend Against Eli Lilly And Co (NYSE:LLY)’s Pricey Portrazza

- May 27, 2016 0
1...118119120...146Page 119 of 146

Latest Articles

  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

July 28, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

July 20, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

July 13, 2025

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016
biotechnology

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

POPULAR CATEGORY

  • SEC Filings97015
  • Analyst Ratings21747
  • Insider Trading7769
  • Earnings4727
  • LSE4165
  • dividend announcements2433
  • Tech News1583
  • Stocks1511
  • Stock Market News1478
Market Exclusive #1 Financial News & Analysis
ABOUT US
Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.
Contact us: [email protected]
FOLLOW US
Facebook Linkedin Tumblr Twitter
  • SEC Filings
  • Stocks
  • Stock Market News
  • Tech News
  • Biotech Stocks
  • Featured
  • Small Caps
  • gold
  • Other News
  • Oil
  • Become a Contributor!
  • Advertise On Market Exclusive
  • Contact Us
© Market Exclusive 2019